Global ED Treatment Market Research Report 2021

1 ED Treatment Market Overview
1.1 Product Overview and Scope of ED Treatment
1.2 ED Treatment Segment by Type
1.2.1 Global ED Treatment Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Sildenafil
1.2.3 Tadalafil
1.2.4 Others
1.3 ED Treatment Segment by Application
1.3.1 ED Treatment Sales Comparison by Application: (2021-2027)
1.3.2 Hospitals
1.3.3 Drugstores
1.3.4 Other
1.4 Global ED Treatment Market Size Estimates and Forecasts
1.4.1 Global ED Treatment Revenue 2016-2027
1.4.2 Global ED Treatment Sales 2016-2027
1.4.3 ED Treatment Market Size by Region: 2016 Versus 2021 Versus 2027

2 ED Treatment Market Competition by Manufacturers
2.1 Global ED Treatment Sales Market Share by Manufacturers (2016-2021)
2.2 Global ED Treatment Revenue Market Share by Manufacturers (2016-2021)
2.3 Global ED Treatment Average Price by Manufacturers (2016-2021)
2.4 Manufacturers ED Treatment Manufacturing Sites, Area Served, Product Type
2.5 ED Treatment Market Competitive Situation and Trends
2.5.1 ED Treatment Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest ED Treatment Players Market Share by Revenue
2.5.3 Global ED Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 ED Treatment Retrospective Market Scenario by Region
3.1 Global ED Treatment Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global ED Treatment Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America ED Treatment Market Facts & Figures by Country
3.3.1 North America ED Treatment Sales by Country
3.3.2 North America ED Treatment Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe ED Treatment Market Facts & Figures by Country
3.4.1 Europe ED Treatment Sales by Country
3.4.2 Europe ED Treatment Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific ED Treatment Market Facts & Figures by Region
3.5.1 Asia Pacific ED Treatment Sales by Region
3.5.2 Asia Pacific ED Treatment Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America ED Treatment Market Facts & Figures by Country
3.6.1 Latin America ED Treatment Sales by Country
3.6.2 Latin America ED Treatment Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa ED Treatment Market Facts & Figures by Country
3.7.1 Middle East and Africa ED Treatment Sales by Country
3.7.2 Middle East and Africa ED Treatment Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global ED Treatment Historic Market Analysis by Type
4.1 Global ED Treatment Sales Market Share by Type (2016-2021)
4.2 Global ED Treatment Revenue Market Share by Type (2016-2021)
4.3 Global ED Treatment Price by Type (2016-2021)

5 Global ED Treatment Historic Market Analysis by Application
5.1 Global ED Treatment Sales Market Share by Application (2016-2021)
5.2 Global ED Treatment Revenue Market Share by Application (2016-2021)
5.3 Global ED Treatment Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Eli Lilly
6.1.1 Eli Lilly Corporation Information
6.1.2 Eli Lilly Description and Business Overview
6.1.3 Eli Lilly ED Treatment Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Eli Lilly Product Portfolio
6.1.5 Eli Lilly Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer ED Treatment Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Pfizer Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Bayer
6.3.1 Bayer Corporation Information
6.3.2 Bayer Description and Business Overview
6.3.3 Bayer ED Treatment Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Bayer Product Portfolio
6.3.5 Bayer Recent Developments/Updates
6.4 BaiYunShan General Factory
6.4.1 BaiYunShan General Factory Corporation Information
6.4.2 BaiYunShan General Factory Description and Business Overview
6.4.3 BaiYunShan General Factory ED Treatment Sales, Revenue and Gross Margin (2016-2021)
6.4.4 BaiYunShan General Factory Product Portfolio
6.4.5 BaiYunShan General Factory Recent Developments/Updates
6.5 S.K. Chemicals
6.5.1 S.K. Chemicals Corporation Information
6.5.2 S.K. Chemicals Description and Business Overview
6.5.3 S.K. Chemicals ED Treatment Sales, Revenue and Gross Margin (2016-2021)
6.5.4 S.K. Chemicals Product Portfolio
6.5.5 S.K. Chemicals Recent Developments/Updates
6.6 Teva Pharma
6.6.1 Teva Pharma Corporation Information
6.6.2 Teva Pharma Description and Business Overview
6.6.3 Teva Pharma ED Treatment Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Teva Pharma Product Portfolio
6.6.5 Teva Pharma Recent Developments/Updates
6.7 Dong-A ST
6.6.1 Dong-A ST Corporation Information
6.6.2 Dong-A ST Description and Business Overview
6.6.3 Dong-A ST ED Treatment Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Dong-A ST Product Portfolio
6.7.5 Dong-A ST Recent Developments/Updates
6.8 Metuchen Pharma
6.8.1 Metuchen Pharma Corporation Information
6.8.2 Metuchen Pharma Description and Business Overview
6.8.3 Metuchen Pharma ED Treatment Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Metuchen Pharma Product Portfolio
6.8.5 Metuchen Pharma Recent Developments/Updates
6.9 Seoul Pharma
6.9.1 Seoul Pharma Corporation Information
6.9.2 Seoul Pharma Description and Business Overview
6.9.3 Seoul Pharma ED Treatment Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Seoul Pharma Product Portfolio
6.9.5 Seoul Pharma Recent Developments/Updates
6.10 CSBIO.
6.10.1 CSBIO. Corporation Information
6.10.2 CSBIO. Description and Business Overview
6.10.3 CSBIO. ED Treatment Sales, Revenue and Gross Margin (2016-2021)
6.10.4 CSBIO. Product Portfolio
6.10.5 CSBIO. Recent Developments/Updates

7 ED Treatment Manufacturing Cost Analysis
7.1 ED Treatment Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of ED Treatment
7.4 ED Treatment Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 ED Treatment Distributors List
8.3 ED Treatment Customers

9 ED Treatment Market Dynamics
9.1 ED Treatment Industry Trends
9.2 ED Treatment Growth Drivers
9.3 ED Treatment Market Challenges
9.4 ED Treatment Market Restraints

10 Global Market Forecast
10.1 ED Treatment Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of ED Treatment by Type (2022-2027)
10.1.2 Global Forecasted Revenue of ED Treatment by Type (2022-2027)
10.2 ED Treatment Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of ED Treatment by Application (2022-2027)
10.2.2 Global Forecasted Revenue of ED Treatment by Application (2022-2027)
10.3 ED Treatment Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of ED Treatment by Region (2022-2027)
10.3.2 Global Forecasted Revenue of ED Treatment by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables
Table 1. Global ED Treatment Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global ED Treatment Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global ED Treatment Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers ED Treatment Covered in This Study
Table 5. Global ED Treatment Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global ED Treatment Sales Share by Manufacturers (2016-2021)
Table 7. Global ED Treatment Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global ED Treatment Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market ED Treatment Average Price (USD/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers ED Treatment Manufacturing Sites and Area Served
Table 11. Manufacturers ED Treatment Product Type
Table 12. Global ED Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global ED Treatment by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in ED Treatment as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global ED Treatment Sales by Region (2016-2021) & (K Units)
Table 16. Global ED Treatment Sales Market Share by Region (2016-2021)
Table 17. Global ED Treatment Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America ED Treatment Sales by Country (2016-2021) & (K Units)
Table 19. North America ED Treatment Sales Market Share by Country (2016-2021)
Table 20. North America ED Treatment Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America ED Treatment Revenue Market Share by Country (2016-2021)
Table 22. Europe ED Treatment Sales by Country (2016-2021) & (K Units)
Table 23. Europe ED Treatment Sales Market Share by Country (2016-2021)
Table 24. Europe ED Treatment Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe ED Treatment Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific ED Treatment Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific ED Treatment Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific ED Treatment Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific ED Treatment Revenue Market Share by Region (2016-2021)
Table 30. Latin America ED Treatment Sales by Country (2016-2021) & (K Units)
Table 31. Latin America ED Treatment Sales Market Share by Country (2016-2021)
Table 32. Latin America ED Treatment Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America ED Treatment Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa ED Treatment Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa ED Treatment Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa ED Treatment Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa ED Treatment Revenue Market Share by Country (2016-2021)
Table 38. Global ED Treatment Sales (K Units) by Type (2016-2021)
Table 39. Global ED Treatment Sales Market Share by Type (2016-2021)
Table 40. Global ED Treatment Revenue (Million US$) by Type (2016-2021)
Table 41. Global ED Treatment Revenue Share by Type (2016-2021)
Table 42. Global ED Treatment Price (USD/Unit) by Type (2016-2021)
Table 43. Global ED Treatment Sales (K Units) by Application (2016-2021)
Table 44. Global ED Treatment Sales Market Share by Application (2016-2021)
Table 45. Global ED Treatment Revenue (Million US$) by Application (2016-2021)
Table 46. Global ED Treatment Revenue Share by Application (2016-2021)
Table 47. Global ED Treatment Price (USD/Unit) by Application (2016-2021)
Table 48. Eli Lilly Corporation Information
Table 49. Eli Lilly Description and Business Overview
Table 50. Eli Lilly ED Treatment Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 51. Eli Lilly ED Treatment Product
Table 52. Eli Lilly Recent Developments/Updates
Table 53. Pfizer Corporation Information
Table 54. Pfizer Description and Business Overview
Table 55. Pfizer ED Treatment Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 56. Pfizer ED Treatment Product
Table 57. Pfizer Recent Developments/Updates
Table 58. Bayer Corporation Information
Table 59. Bayer Description and Business Overview
Table 60. Bayer ED Treatment Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 61. Bayer ED Treatment Product
Table 62. Bayer Recent Developments/Updates
Table 63. BaiYunShan General Factory Corporation Information
Table 64. BaiYunShan General Factory Description and Business Overview
Table 65. BaiYunShan General Factory ED Treatment Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 66. BaiYunShan General Factory ED Treatment Product
Table 67. BaiYunShan General Factory Recent Developments/Updates
Table 68. S.K. Chemicals Corporation Information
Table 69. S.K. Chemicals Description and Business Overview
Table 70. S.K. Chemicals ED Treatment Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 71. S.K. Chemicals ED Treatment Product
Table 72. S.K. Chemicals Recent Developments/Updates
Table 73. Teva Pharma Corporation Information
Table 74. Teva Pharma Description and Business Overview
Table 75. Teva Pharma ED Treatment Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 76. Teva Pharma ED Treatment Product
Table 77. Teva Pharma Recent Developments/Updates
Table 78. Dong-A ST Corporation Information
Table 79. Dong-A ST Description and Business Overview
Table 80. Dong-A ST ED Treatment Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 81. Dong-A ST ED Treatment Product
Table 82. Dong-A ST Recent Developments/Updates
Table 83. Metuchen Pharma Corporation Information
Table 84. Metuchen Pharma Description and Business Overview
Table 85. Metuchen Pharma ED Treatment Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 86. Metuchen Pharma ED Treatment Product
Table 87. Metuchen Pharma Recent Developments/Updates
Table 88. Seoul Pharma Corporation Information
Table 89. Seoul Pharma Description and Business Overview
Table 90. Seoul Pharma ED Treatment Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 91. Seoul Pharma ED Treatment Product
Table 92. Seoul Pharma Recent Developments/Updates
Table 93. CSBIO. Corporation Information
Table 94. CSBIO. Description and Business Overview
Table 95. CSBIO. ED Treatment Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 96. CSBIO. ED Treatment Product
Table 97. CSBIO. Recent Developments/Updates
Table 98. Production Base and Market Concentration Rate of Raw Material
Table 99. Key Suppliers of Raw Materials
Table 100. ED Treatment Distributors List
Table 101. ED Treatment Customers List
Table 102. ED Treatment Market Trends
Table 103. ED Treatment Growth Drivers
Table 104. ED Treatment Market Restraints
Table 105. Global ED Treatment Sales Forecast by Type (2022-2027) & (K Units)
Table 106. Global ED Treatment Sales Market Share Forecast by Type (2022-2027)
Table 107. Global ED Treatment Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 108. Global ED Treatment Revenue Market Share Forecast by Type (2022-2027)
Table 109. Global ED Treatment Sales Forecast by Application (2022-2027) & (K Units)
Table 110. Global ED Treatment Sales Market Share Forecast by Application (2022-2027)
Table 111. Global ED Treatment Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 112. Global ED Treatment Revenue Market Share Forecast by Application (2022-2027)
Table 113. Global ED Treatment Sales Forecast by Region (2022-2027) & (K Units)
Table 114. Global ED Treatment Sales Market Share Forecast by Region (2022-2027)
Table 115. Global ED Treatment Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 116. Global ED Treatment Revenue Market Share Forecast by Region (2022-2027)
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of ED Treatment
Figure 2. Global ED Treatment Market Share by Type in 2020 & 2027
Figure 3. Sildenafil Product Picture
Figure 4. Tadalafil Product Picture
Figure 5. Others Product Picture
Figure 6. Global ED Treatment Market Share by Application in 2020 & 2027
Figure 7. Hospitals
Figure 8. Drugstores
Figure 9. Other
Figure 10. Global ED Treatment Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global ED Treatment Market Size 2016-2027 (US$ Million)
Figure 12. Global ED Treatment Sales 2016-2027 (K Units)
Figure 13. Global ED Treatment Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 14. ED Treatment Sales Share by Manufacturers in 2020
Figure 15. Global ED Treatment Revenue Share by Manufacturers in 2020
Figure 16. The Global 5 and 10 Largest ED Treatment Players: Market Share by Revenue in 2020
Figure 17. ED Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 18. Global ED Treatment Sales Market Share by Region (2016-2021)
Figure 19. Global ED Treatment Sales Market Share by Region in 2020
Figure 20. Global ED Treatment Revenue Market Share by Region (2016-2021)
Figure 21. Global ED Treatment Revenue Market Share by Region in 2020
Figure 22. U.S. ED Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Canada ED Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Germany ED Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. France ED Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. U.K. ED Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Italy ED Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Russia ED Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. China ED Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Japan ED Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. South Korea ED Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. India ED Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Australia ED Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Taiwan ED Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Indonesia ED Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Thailand ED Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Malaysia ED Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Philippines ED Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Vietnam ED Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Mexico ED Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Brazil ED Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Argentina ED Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Turkey ED Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Saudi Arabia ED Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. U.A.E ED Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Sales Market Share of ED Treatment by Type (2016-2021)
Figure 47. Sales Market Share of ED Treatment by Application (2016-2021)
Figure 48. Sales Market Share of ED Treatment by Application in 2020
Figure 49. Revenue Share of ED Treatment by Application (2016-2021)
Figure 50. Revenue Share of ED Treatment by Application in 2020
Figure 51. Manufacturing Cost Structure of ED Treatment
Figure 52. Manufacturing Process Analysis of ED Treatment
Figure 53. ED Treatment Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.